Literature DB >> 32292164

Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest.

Sara Marelli1,2, James C Williamson1,2, Anna V Protasio1,2, Adi Naamati1,2, Edward Jd Greenwood1,2, Janet E Deane3,4, Paul J Lehner1,2, Nicholas J Matheson1,2.   

Abstract

The seminal description of the cellular restriction factor APOBEC3G and its antagonism by HIV-1 Vif has underpinned two decades of research on the host-virus interaction. We recently reported that HIV-1 Vif is also able to degrade the PPP2R5 family of regulatory subunits of key cellular phosphatase PP2A (PPP2R5A-E; Greenwood et al., 2016; Naamati et al., 2019). We now identify amino acid polymorphisms at positions 31 and 128 of HIV-1 Vif which selectively regulate the degradation of PPP2R5 family proteins. These residues covary across HIV-1 viruses in vivo, favouring depletion of PPP2R5A-E. Through analysis of point mutants and naturally occurring Vif variants, we further show that degradation of PPP2R5 family subunits is both necessary and sufficient for Vif-dependent G2/M cell cycle arrest. Antagonism of PP2A by HIV-1 Vif is therefore independent of APOBEC3 family proteins, and regulates cell cycle progression in HIV-infected cells.
© 2020, Marelli et al.

Entities:  

Keywords:  HIV; PP2A; Vif; cell cycle; infectious disease; microbiology; virus

Mesh:

Substances:

Year:  2020        PMID: 32292164      PMCID: PMC7920553          DOI: 10.7554/eLife.53036

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  87 in total

1.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

2.  Clustal Omega, accurate alignment of very large numbers of sequences.

Authors:  Fabian Sievers; Desmond G Higgins
Journal:  Methods Mol Biol       Date:  2014

3.  Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.

Authors:  Ke Zhao; Juan Du; Yajuan Rui; Wenwen Zheng; Jian Kang; Jingwei Hou; Kang Wang; Wenyan Zhang; Viviana A Simon; Xiao-Fang Yu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

5.  Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes.

Authors:  J H Simon; T E Southerling; J C Peterson; B E Meyer; M H Malim
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

7.  APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

Authors:  Gregory Berger; Stéphanie Durand; Guillaume Fargier; Xuan-Nhi Nguyen; Stéphanie Cordeil; Serge Bouaziz; Delphine Muriaux; Jean-Luc Darlix; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

8.  Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection.

Authors:  Edward J D Greenwood; James C Williamson; Agata Sienkiewicz; Adi Naamati; Nicholas J Matheson; Paul J Lehner
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

9.  Division of labour between PP2A-B56 isoforms at the centromere and kinetochore.

Authors:  Giulia Vallardi; Lindsey A Allan; Lisa Crozier; Adrian T Saurin
Journal:  Elife       Date:  2019-03-04       Impact factor: 8.140

10.  Relative resistance of HIV-1 founder viruses to control by interferon-alpha.

Authors:  Angharad E Fenton-May; Oliver Dibben; Tanja Emmerich; Haitao Ding; Katja Pfafferott; Marlen M Aasa-Chapman; Pierre Pellegrino; Ian Williams; Myron S Cohen; Feng Gao; George M Shaw; Beatrice H Hahn; Christina Ochsenbauer; John C Kappes; Persephone Borrow
Journal:  Retrovirology       Date:  2013-12-03       Impact factor: 4.602

View more
  8 in total

1.  A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.

Authors:  Sizhu Duan; Shiqi Wang; Yanan Song; Nan Gao; Lina Meng; Yanxin Gai; Ying Zhang; Song Wang; Chu Wang; Bin Yu; Jiaxin Wu; Xianghui Yu
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

Review 2.  Demystifying Cell Cycle Arrest by HIV-1 Vif.

Authors:  Daniel J Salamango; Reuben S Harris
Journal:  Trends Microbiol       Date:  2021-01-19       Impact factor: 17.079

Review 3.  Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest.

Authors:  Daniel J Salamango; Reuben S Harris
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

4.  Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.

Authors:  Paige Haas; Monita Muralidharan; Nevan J Krogan; Robyn M Kaake; Ruth Hüttenhain
Journal:  J Proteome Res       Date:  2021-01-19       Impact factor: 4.466

5.  Evolutionary Conservation of PP2A Antagonism and G2/M Cell Cycle Arrest in Maedi-Visna Virus Vif.

Authors:  Adeline M Luperchio; Stefán R Jónsson; Daniel J Salamango
Journal:  Viruses       Date:  2022-08-01       Impact factor: 5.818

6.  APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans.

Authors:  Rayhane Nchioua; Dorota Kmiec; Amit Gaba; Christina M Stürzel; Tyson Follack; Stephen Patrick; Andrea Kirmaier; Welkin E Johnson; Beatrice H Hahn; Linda Chelico; Frank Kirchhoff
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

Review 7.  Cell Cycle Regulation in Macrophages and Susceptibility to HIV-1.

Authors:  Isabella A T M Ferreira; J Zachary Porterfield; Ravindra K Gupta; Petra Mlcochova
Journal:  Viruses       Date:  2020-07-31       Impact factor: 5.048

8.  Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest.

Authors:  Sara Marelli; James C Williamson; Anna V Protasio; Adi Naamati; Edward Jd Greenwood; Janet E Deane; Paul J Lehner; Nicholas J Matheson
Journal:  Elife       Date:  2020-04-15       Impact factor: 8.713

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.